- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-20-0048506

About Resona Pharmaceutical Limited
Data last updated:
Resona Pharmaceutical Limited is a public limited company based in Salem, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33110TZ2021PLC035879.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shanmugavadivu Thotta Kuppuraj and Sathish Kannan Duraisamy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 253/8 Arun Nagar Annexe Iyer Thottam Periyapuddur, Salem, Tamil Nadu, India – 636016.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.9 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.11 Lakh (net margin 12.5%) and EBITDA of ₹3 Lakh (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years.
Resona Pharmaceutical Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-20-0048506). For more details, the company can be reached via its website resonapharma.com.
Company details
Recognitions & Rankings of Resona Pharmaceutical
Contact details
Resona Pharmaceutical Limited's registered office is in Salem, Tamil Nadu. Its website is resonapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address253/8 Arun Nagar Annexe Iyer Thottam Periyapuddur, Salem, Tamil Nadu, India – 636016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Resona Pharmaceutical Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Resona Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Resona Pharmaceutical Limited, buy the company report.
Financials of Resona Pharmaceutical Limited
FY 2025 filings availableResona Pharmaceutical Limited reported revenue of ₹16.9 Lakh (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over three years, including 2% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.11 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 17.8% | |||
| Net Profit Margin | 12.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Resona Pharmaceutical Limited, buy the company report.
Board of directors of Resona Pharmaceutical Limited
Resona Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shanmugavadivu Thotta Kuppuraj Also directs: Clazy Pension Tree Limited, Clazy Resort World Private Limited, 1890S Coffee House Private Limited and 5 more | Director | 23 Mar 2021 | 5 Years 7 Months | Current |
| Sathish Kannan Duraisamy Also directs: Clazy Pension Tree Limited, Velova Coal and Eco Power India Private Limited, Pit Auto EV India Private Limited and 5 more | Director | 23 Mar 2021 | 5 Years 7 Months | Current |
| Senthilvelan Duraisamy Also directs: Pit Auto EV India Private Limited, Resona Aerospace & Research Limited, Resona Hospitals & Research Institute Limited and 1 more | Director | 01 Oct 2024 | 2 Years 1 Months | Current |
Peer comparison
Resona Pharmaceutical Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mozan Impex Private Limited | ₹16.91 Lakh (FY 2023) | Bokaro, Jharkhand, India | ||||
| Branded Baba Private Limited | ₹16.9 Lakh (FY 2025) | 7.0% | Delhi, India | |||
| Old Town Jewels Private Limited | ₹16.9 Lakh (FY 2025) | -8.0% | Delhi, India | |||
| Kiyansh Industries Private Limited | ₹16.9 Lakh (FY 2025) | -65.0% | Rajkot, Gujarat, India | |||
| Alpana Interiors Private Limited | ₹16.9 Lakh (FY 2021) | -57.0% | Uttar Pradesh, India | |||
| Resona Pharmaceutical Limitedthis company | ₹16.9 Lakh (FY 2024) | ₹2.11 Lakh | 12.5% | 2.0% | Salem, Tamil Nadu, India | |
| Esjay IT Solutions Private Limited | ₹16.9 Lakh (FY 2021) | 87.0% | Rajkot, Gujarat, India | |||
| Gramraj Ventures Private Limited | ₹16.89 Lakh (FY 2024) | 10138.0% | Bhopal, Madhya Pradesh, India | |||
| Niveditha Marketing Private Limited | ₹16.89 Lakh (FY 2024) | -34.0% | Kothur (Mdl), Telangana, India | |||
| Zenell Sciences Private Limited | ₹16.89 Lakh (FY 2024) | Meerut, Uttar Pradesh, India | ||||
| Sila Silpa (OPC) Private Limited | ₹16.88 Lakh (FY 2024) | 15.0% | Rayagada, Odisha, India |
To see the full peer comparison of Resona Pharmaceutical Limited, buy the company report.
Auditor
Resona Pharmaceutical Limited is audited by RM Veerappan for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RM Veerappan | FY 2023 | 214262 |
Shareholding
The shareholding of Resona Pharmaceutical Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Resona Pharmaceutical Limited, buy the company report.
Legal cases
No court or tribunal cases involving Resona Pharmaceutical Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Resona Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Resona Pharmaceutical Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
No GST registration is on our record for Resona Pharmaceutical Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Resona Pharmaceutical Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Senthilvelan Duraisamy was appointed as Director on 01 Oct 2024.
Frequently asked questions
Resona Pharmaceutical is an active public limited company based in Salem, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2021 (5+ years old) and is registered under CIN U33110TZ2021PLC035879.
Resona Pharmaceutical has 3 current directors:
- Shanmugavadivu Thotta Kuppuraj - Director
- Sathish Kannan Duraisamy - Director
- Senthilvelan Duraisamy - Director
The latest financial statements of Resona Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Resona Pharmaceutical is U33110TZ2021PLC035879. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Resona Pharmaceutical was incorporated on 23 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Resona Pharmaceutical by revenue are Mozan Impex Private Limited, Branded Baba Private Limited, Old Town Jewels Private Limited, Kiyansh Industries Private Limited, Alpana Interiors Private Limited and 5 more, all in the same principal business activity (retail trading).
Senthilvelan Duraisamy was appointed as Director on 01 Oct 2024. Suresh Babu Roshan Vijay ceased to be Director on 01 Oct 2024. Sathish Kannan Duraisamy was appointed as Director on 23 Mar 2021. Resona Pharmaceutical has 5 board changes on record in total.
Yes, Resona Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-20-0048506).
Resona Pharmaceutical can be reached through the website resonapharma.com. Its registered office is in Salem, Tamil Nadu, India.
The registered office of Resona Pharmaceutical is at 2538 Arun Nagar Annexe Iyer Thottam Periyapuddur, Salem, Tamil Nadu, India – 636016.
Resona Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

